CARDSUP - SWISS Circulatory Support Registry
- Conditions
- Cardiogenic Shock
- Registration Number
- NCT04117230
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
- Detailed Description
This prospective data collection is made up of an all-comers design, including all eligible consecutive patients receiving an Impella (2.5, 5, CP, or RP) or VA-ECMO device via femoral access who gave their consent (or, if not possible, their relative).
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
- Age > 18 years
- Medical indication for implantation of a peripheral cannulated VA-ECMO or microaxial flow pump (IMPELLA) or newer LV / LA-Ascending Aorta devices.
- Signed informed consent by patient or relative or waived consent by EC
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of deceased participants at 1 month after cardiogenic shock 30 days All-cause mortality at 30 days
- Secondary Outcome Measures
Name Time Method Statistical and medical analysis of vascular complications (VARC) reported by participants 6 months Vascular complications (VARC)
Statistical and medical analysis of vascular surgery needed by participants 6 months Need for vascular surgery
Analysis of New York Heart Association (NYHA) Classification for participants 6 months The New York Heart Association (NYHA) Classification provides a way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity; the limitations/symptoms are in regards to normal breathing and varying degrees in shortness of breath and or angina pain. Class I is defined as no symptoms and no limitation in ordinary physical activity worsening to Class IV defined as severe limitations.
Statistical and medical analysis of major adverse cardiac and cerebrovascular events (MACCE) reported by participants 6 months Major adverse cardiac and cerebrovascular events (MACCE)
Implantation time of MCS-device 6 months Implantation time of MCS-device
Support time under MCS 6 months Support time under MCS
Modified rankin scale 6 months Modified rankin scale measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological Disability. The scale ranges form 0-6 with 0 defined as no Symptoms and 5 being severe Symptoms and 6 defined as death.
Statistical and medical analysis of bleeding complications (minor, major) reported by participants 6 months Bleeding complications (minor, major)
Number of deceased participants at 6 month after cardiogenic shock 6 months Mortality at 6 months
Trial Locations
- Locations (5)
Universitätsspital Basel
🇨đź‡Basel, Switzerland
Insel Gruppe AG, Inselspital Bern
🇨đź‡Bern, Switzerland
Luzerner Kantonsspital
🇨đź‡Luzern, Switzerland
Kantonsspital Winterthur
🇨đź‡Winterthur, Switzerland
Stadtspital Treimli
🇨đź‡ZĂĽrich, Switzerland